# Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine

> **NCT06857370** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **CanSino Biologics Inc.** · enrollment: 780 (actual)

## Conditions studied

- Diphtheria, Tetanus and Acellular Pertussis

## Interventions

- **BIOLOGICAL:** Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 1)
- **BIOLOGICAL:** Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 2)
- **BIOLOGICAL:** Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 3)

## Key facts

- **NCT ID:** NCT06857370
- **Lead sponsor:** CanSino Biologics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-23
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 780 (ACTUAL)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06857370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06857370, "Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06857370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*